Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.

Twelve patients with advanced small cell carcinoma of the bronchus were treated by continuous infusion of recombinant human granulocyte colony-stimulating factor (rhG-CSF) at the following dose levels: 1 microgram, 5 micrograms, 10 micrograms, 20 micrograms and 40 micrograms kg-1 day-1 for 5 days. N...

Descripción completa

Detalles Bibliográficos
Autores principales: Bronchud, M. H., Scarffe, J. H., Thatcher, N., Crowther, D., Souza, L. M., Alton, N. K., Testa, N. G., Dexter, T. M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1987
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002403/
https://www.ncbi.nlm.nih.gov/pubmed/2829955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002403/
https://www.ncbi.nlm.nih.gov/pubmed/2829955

Ejemplares similares